Anders Lund - Novozymes President
| NVZMF Stock | USD 57.90 1.15 1.95% |
President
Mr. Anders Lund was Executive Vice President, Household Care Technical at Novozymes AS since February 8, 2016. Formerly, he was Vice President of Sales at the Company. He holds MS degree in Economics from Aarhus University, Denmark. He started his career with the company in 1999 and has held various leadership positions across Marketing, Sales and as Head of Supply Chain. since 2016.
| Age | 50 |
| Tenure | 8 years |
| Phone | 45 44 46 00 00 |
| Web | https://www.novozymes.com |
Novozymes Management Efficiency
The company has return on total asset (ROA) of 0.1062 % which means that it generated a profit of $0.1062 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2789 %, meaning that it generated $0.2789 on every $100 dollars invested by stockholders. Novozymes' management efficiency ratios could be used to measure how well Novozymes manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Michael Crocco | Air Products and | 58 | |
| Victoria Brifo | Air Products and | 55 | |
| Kristin Esq | Albemarle Corp | 56 | |
| Brian Williams | PPG Industries | N/A | |
| Susan Kelliher | Chemours Co | 57 | |
| Glenn Richter | International Flavors Fragrance | 62 | |
| Susana SuarezGonzalez | International Flavors Fragrance | 51 | |
| Joseph Martinko | Chemours Co | 56 | |
| David Ryan | Albemarle Corp | 49 | |
| Francisco Fortanet | International Flavors Fragrance | 52 | |
| Ramaparasad Vadlamannati | PPG Industries | 61 | |
| Anne Chwat | International Flavors Fragrance | 59 | |
| Alisha Bellezza | Chemours Co | 48 | |
| Matthew Abbott | Chemours Co | 47 | |
| Sean Major | Air Products and | 60 | |
| Ivo Bols | Air Products and | 63 | |
| Netha Johnson | Albemarle Corp | 53 | |
| Eugene Snell | Chemours Co | 62 | |
| Wilbur Mok | Air Products and | 63 | |
| Edwin Sparks | Chemours Co | 50 | |
| John Barichivich | Albemarle Corp | 53 | |
Management Performance
| Return On Equity | 0.28 | |||
| Return On Asset | 0.11 |
Novozymes AS B Leadership Team
Elected by the shareholders, the Novozymes' board of directors comprises two types of representatives: Novozymes inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novozymes. The board's role is to monitor Novozymes' management team and ensure that shareholders' interests are well served. Novozymes' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novozymes' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pedro Fernandes, Head America | ||
| Tobias Bjorklund, Head of Investor Relations | ||
| Ester Baiget, Pres CEO | ||
| Tue Micheelsen, VP Marketing | ||
| Sebastian Sderberg, VP Acquisitions | ||
| Tina Fanoe, Executive Vice President Agriculture & Bioenergy | ||
| Graziela Malucelli, Supply Operations | ||
| Anders Lund, Executive Vice President Household Care & Technical Industries | ||
| Morten Rasmussen, Sustainability People | ||
| MSc MSc, Ex CFO |
Novozymes Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Novozymes a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.28 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 14.47 B | |||
| Shares Outstanding | 222.86 M | |||
| Shares Owned By Insiders | 8.04 % | |||
| Shares Owned By Institutions | 42.30 % | |||
| Price To Earning | 33.38 X | |||
| Price To Book | 6.19 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Novozymes Pink Sheet
Novozymes financial ratios help investors to determine whether Novozymes Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Novozymes with respect to the benefits of owning Novozymes security.